It has been suggested that AKR1C2 is involved in steroid hormone biosynthesis [20] and ROS formation [21], which can reduce the level of ROS in cancer cells [22], make them resistant to oxidative stress and drug stimulation and ultimately mitigate death [23]. The gene discussed is AKR1C2; the disease is cancer.